Online citations, reference lists, and bibliographies.

Preparation Of Chitosan Nanoparticles Containing Naja Naja Oxiana Snake Venom.

Naser Mohammadpourdounighi, Azam Behfar, Ali Ezabadi, Hosein Zolfagharian, M. Heydari
Published 2010 · Medicine, Materials Science

Cite This
Download PDF
Analyze on Scholarcy
Share
UNLABELLED Hydrophilic nanoparticles have received much attention for delivery of therapeutic peptides, proteins, and antigens. Chitosan (CS) is a biodegradable and nontoxic polysaccharide, as a carrier for drug delivery. The study purpose was to evaluate the influence of a number of factors on the encapsulation of Naja naja oxiana (Indian or speckled cobra) venom and loading capacity, as well as to investigate the physicochemical structure of nanoparticles. CS nanoparticles were produced based on the ionic gelation process of tripolyphosphate (TPP) and CS. All the preparations were estimated with diameter 120-150 nm and spherical shape using transmission electron microscopy. Fourier transform-infrared spectroscopy confirmed that tripolyphosphoric groups of TPP linked with ammonium groups of CS in the nanoparticles. Our results showed that CS can react with TPP to form stable cationic nanoparticles. Therefore, when chitosan concentration was increased to 1.5 mg/mL the aggregates with large diameter were formed. Optimum loading capacity and encapsulation efficiency of venom at a concentration of 500 microg/mL were achieved for low-molecular-weight (low-MW) CS at a concentration of 2 mg/mL and high-MW CS at a concentration of 3 mg/mL. FROM THE CLINICAL EDITOR In this study a hydrophilic nanoparticle chitosan was investigated as a protein delivery system, and optimum conditions were established for future use of this technology.
This paper references
10.1016/j.nano.2008.09.006
Preparation and in vitro evaluation of mucoadhesion and permeation enhancement of thiolated chitosan-pHEMA core-shell nanoparticles.
Firooze Aghaei Moghaddam (2009)
10.1023/B:PHAM.0000026432.75781.cb
Chitosan Nanoparticles as New Ocular Drug Delivery Systems: in Vitro Stability, in Vivo Fate, and Cellular Toxicity
A. M. de Campos (2004)
10.1002/jbm.b.31161
Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin.
X. Wang (2009)
10.1023/A:1018908705446
Enhancement of Nasal Absorption of Insulin Using Chitosan Nanoparticles
R. Fernández-Urrusuno (2004)
10.1016/S0141-8130(00)00118-5
Chitosan as an enabling excipient for drug delivery systems. I. Molecular modifications.
S. Sabnis (2000)
10.1016/S0168-3659(00)00361-8
Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency.
H. Mao (2001)
10.1002/APP.12016
Depolymerized chitosan nanoparticles for protein delivery: Preparation and characterization
Kevin A. Janes (2003)
10.1021/JS970018G
Chitosan Capsules for Colon-Specific Drug Delivery: Improvement of Insulin Absorption from the Rat Colon
H. Tozaki (1997)
10.1016/S0928-0987(99)00032-9
Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.
N. G. Schipper (1999)
10.1016/0142-9612(94)90209-7
Incorporation of basic fibroblast growth factor into methylpyrrolidinone chitosan fleeces and determination of the in vitro release characteristics.
P. C. Berscht (1994)
10.1016/S1672-2515(07)60026-8
Effects of surfactant and acid type on preparation of chitosan microcapsules
Z. Yang (2004)
10.1016/0378-5173(93)90317-9
Hydrocolloids and gels of chitosan as drug carriers
J. Kristl (1993)
10.1248/cpb.38.2871
Release characteristics of cisplatin chitosan microspheres and effect of containing chitin.
Y. Nishioka (1990)
10.1016/S0169-409X(01)00180-6
Chitosan and its derivatives as intestinal absorption enhancers.
M. Thanou (2001)
10.1023/A:1018967116988
Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2)
P. Artursson (2004)
10.22092/ARI.2006.103722
Preparation and evaluation of chitosan nanoparticles containing Diphtheria toxoid as new carriers for nasal vaccine delivery in mice
A. Mokarram (2006)
10.1016/S0378-5173(02)00486-6
Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo.
Yan Pan (2002)
Chitin and chitosan : sources, chemistry, biochemistry, physical properties, and applications
T. Anthonsen (1989)
10.1023/A:1011929016601
Chitosan and its use as a pharmaceutical excipient.
L. Illum (1998)
10.1007/978-94-011-5942-5
Advances in chitin and chitosan
C. Brine (1992)
10.1016/J.CARBPOL.2008.01.015
Thiolated chitosan coated poly hydroxyethyl methacrylate nanoparticles: Synthesis and characterization
Fatemeh Atyabi (2008)
10.1080/15321799508014592
Microcapsules/Microspheres Related to Chitosan
K. Yao (1995)
10.1002/(SICI)1097-4628(19990624)72:13<1721::AID-APP8>3.0.CO;2-V
Improved mechanical properties of chitosan fibers
Jonathan Z. Knaul (1999)
10.1016/S0169-409X(00)00123-X
Polysaccharide colloidal particles as delivery systems for macromolecules.
K. Janes (2001)
10.1023/A:1016009313548
Enteral Absorption of Insulin in Rats from Mucoadhesive Chitosan-Coated Liposomes
H. Takeuchi (2004)
10.1016/S0378-5173(99)00030-7
Effect of chitosan on epithelial permeability and structure.
V. Dodane (1999)
10.1248/cpb.33.2107
Preparation of a prolonged release tablet of aspirin with chitosan.
Y. Kawashima (1985)
10.1166/JNN.2009.J01A
A Special Issue on : Advanced Materials for Nanoscience and Nanotechnology
Katsuhiko Ariga (2009)
10.1071/bi9550530
Studies on Chitin
R. Hackman (1955)
10.1021/js960182o
Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers.
T. Aspden (1997)
10.1023/A:1016444808000
Chitosans as Absorption Enhancers for Poorly Absorbable Drugs. 1: Influence of Molecular Weight and Degree of Acetylation on Drug Transport Across Human Intestinal Epithelial (Caco-2) Cells
N. G. Schipper (2004)
10.1007/978-1-4899-0768-4_28
Chitosan: A Biocompatible Material for Oral and Intravenous Administrations
S. Hirano (1990)
10.1166/jnn.2009.1090
Thiolated chitosan nanoparticles as an oral delivery system for Amikacin: in vitro and ex vivo evaluations.
Fatemeh Atyabi (2009)
10.1002/jps.21550
Modified chitosans for oral drug delivery.
M. Werle (2009)
10.1016/S0168-3659(01)00517-X
Factors affecting protein release from alginate-chitosan coacervate microcapsules during production and gastric/intestinal simulation.
G. Vandenberg (2001)
10.1002/jps.2600740308
Novel method for the preparation of controlled-release theophylline granules coated with a polyelectrolyte complex of sodium polyphosphate-chitosan.
Y. Kawashima (1985)
10.1248/cpb.33.2469
The effects of thickness and hardness of the coating film on the drug release rate of theophylline granules coated with chitosan-sodium tripolyphosphate complex.
Y. Kawashima (1985)
10.3109/02652049709006820
Chitosan: properties, preparations and application to microparticulate systems.
H. Kaş (1997)
10.1023/A:1012128907225
Chitosan and Chitosan/Ethylene Oxide-Propylene Oxide Block Copolymer Nanoparticles as Novel Carriers for Proteins and Vaccines
P. Calvo (2004)
10.1111/j.2042-7158.1992.tb03607.x
Cross-linked chitosan microspheres: preparation and evaluation as a matrix for the controlled release of pharmaceuticals.
B. C. Thanoo (1992)
10.1007/978-1-4899-0768-4
Progress in Biomedical Polymers
C. G. Gebelein (1990)
10.3109/03639049809089942
Chitosan: a unique polysaccharide for drug delivery.
O. Felt (1998)
10.1016/S1461-5347(98)00059-5
Pharmaceutical applications of chitosan
V. Dodane (1998)
10.1002/macp.1976.021771210
Studies on chitin, 2†. Effect of deacetylation on solubility
T. Sannan (1976)
10.1016/0378-5173(93)90100-T
The effect of the physicochemical properties of a drug on its release from chitosonium malate matrix tablets
J. Akbuǧa (1993)
10.1016/S0378-5173(03)00202-3
Effect of chitosan on progesterone release from hydroxypropyl-beta-cyclodextrin complexes.
T. Cerchiara (2003)
10.1016/J.IJPHARM.2005.01.042
Chitosan nanoparticles as a novel delivery system for ammonium glycyrrhizinate.
Yan Wu (2005)



This paper is referenced by
10.3390/ma12152445
Use of Biopolymers in Mucosally-Administered Vaccinations for Respiratory Disease
Margaret R Dedloff (2019)
10.1007/s40005-017-0324-x
Fabrication and characterization of mucoadhesive topical nanoformulations of dorzolamide HCl for ocular hypertension
Satish Manchanda (2017)
10.1590/S1678-91992012000100006
Preparation and in vitro characterization of chitosan nanoparticles containing Mesobuthus eupeus scorpion venom as an antigen delivery system
N. M. Dounighi (2012)
10.35118/apjmbb.2019.027.4.09
Synthesis and characterisation of chitosan nanoparticle as a potential delivery carrier
Noor Hidayah Ibrahim (2019)
10.1016/j.ijbiomac.2017.09.094
Delivery of viral recombinant VP28 protein using chitosan tripolyphosphate nanoparticles to protect the whiteleg shrimp, Litopenaeus vannamei from white spot syndrome virus infection.
G. Taju (2018)
10.1177/0022034513494816
Effects of Chitosan Particles in Periodontal Pathogens and Gingival Fibroblasts
Rodrigo García Arancibia (2013)
10.15171/ijb.1360
Antimicrobial Activity of Chitosan Film Forming Solution Enriched with Essential Oils; an in Vitro Assay.
Kana Jean Raphaël (2017)
10.1016/j.carbpol.2017.08.082
Application, mode of action, and in vivo activity of chitosan and its micro- and nanoparticles as antimicrobial agents: A review.
Z. Ma (2017)
10.22037/IJPR.2017.2092
A New Approach to Antivenom Preparation Using Chitosan Nanoparticles Containing EchisCarinatus Venom as A Novel Antigen Delivery System
F. Mirzaei (2017)
10.1016/j.actatropica.2013.07.013
Chitosan tripolyphosphate (CS/TPP) nanoparticles: preparation, characterization and application for gene delivery in shrimp.
S. Vimal (2013)
10.7508/ARI.2015.04.007
Preparation, characterization and stability investigation of chitosan nanoparticles loaded with the Echis carinatus snake venom as a novel delivery system
N. poMohammadur Dounighi (2015)
10.1016/B978-0-323-47720-8.00012-2
Nanosystems for oral delivery of immunomodulators
Prachi Balaram Kharkar (2017)
Synthesis and characterization of dye coated fluorescent chitosan nanoparticles
K. Chitra (2014)
10.21276/IJLSSR.2018.4.2.17
Preparation of Chitosan Nanoparticles and their In-vitro Characterization
Megha Agarwal (2018)
10.5829/idosi.ije.2017.30.04a.01
Survival of Lactobacillus Acidophilus as Probiotic Bacteria using Chitosan Nanoparticles
P. Ebrahimnejad (2017)
10.2174/1389201020666190621104624
Encapsulation of venom-derived peptides and toxins for pharmaceutical application.
Ana Paula dos Santos (2019)
10.1002/jps.24617
Spray Freeze-Drying as an Alternative to the Ionic Gelation Method to Produce Chitosan and Alginate Nano-Particles Targeted to the Colon.
A. Gamboa (2015)
10.3892/etm.2014.1643
Effect of erythropoietin loading chitosan-tripolyphosphate nanoparticles on an IgA nephropathy rat model
Xiaoli Zhang (2014)
10.1016/J.AQUACULTURE.2012.06.012
Synthesis and characterization of CS/TPP nanoparticles for oral delivery of gene in fish
S. C. Vimal (2012)
10.3390/md14100182
Development and Characterization of VEGF165-Chitosan Nanoparticles for the Treatment of Radiation-Induced Skin Injury in Rats
Daojiang Yu (2016)
10.1016/J.JMMM.2014.12.076
Preparation and characterization of magnetic Fe3O4–chitosan nanoparticles loaded with isoniazid
H. Qin (2015)
10.1002/jbt.21502
Synthesis and characterization of chitosan tripolyphosphate nanoparticles and its encapsulation efficiency containing Russell's viper snake venom.
C. Venkatesan (2013)
Comparative Cytotoxic Evaluation of Free and Sodium Alginate Nanoparticle-Encapsulated ICD-85 on Primary Lamb Kidney Cells
Abbas Zare Mirakabadi (2013)
10.1186/S40689-016-0016-3
Removal of heavy metal chromium from tannery effluent using ultrafiltration membrane
P. Angelin Vinodhini (2016)
Nanoparticle-conjugated animal venom-toxins and their possible therapeutic potential
Archita Biswas (2012)
10.7508/ARI.2013.01.001
Progress and improvement of the manufacturing process of snake antivenom
H. Zolfagharian (2013)
10.22092/ARI.2009.103840
Encapsulation of Naja-Naja oxiana snake venom into poly (lactide-co-glycolide) microspheres.
Naser Mohammadpour Dounighi (2009)
10.1016/j.ijpharm.2015.05.065
Design, characterisation, and bioefficiency of insulin-chitosan nanoparticles after stabilisation by freeze-drying or cross-linking.
M'boypa Diop (2015)
10.1016/J.MOLLIQ.2017.06.071
Self-assembled scorpion venom proteins cross-linked chitosan nanoparticles for use in the immunotherapy
Karla Samara Rocha Soares (2017)
10.1016/j.ejps.2011.06.007
Engineering tenofovir loaded chitosan nanoparticles to maximize microbicide mucoadhesion.
Jianing Meng (2011)
10.4331/wjbc.v8.i1.4
Modern trends in animal venom research - omics and nanomaterials
Y. Utkin (2017)
Extended Immunization of Rats using Microencapsulated Cobra Venom
Aly A. Fahmy (2011)
See more
Semantic Scholar Logo Some data provided by SemanticScholar